Dabur Gets Green Light for Sesa Care Amalgamation

Dabur, a home-grown FMCG company, received a 'no adverse observations' letter from BSE regarding its Scheme of Amalgamation with Sesa Care. The scheme remains subject to further statutory and shareholder approvals. Dabur acquired a majority stake in Sesa Care in 2024, and the full merger was approved in 2025.

Devdiscourse News Desk | New Delhi | Updated: 05-12-2025 20:32 IST | Created: 05-12-2025 20:32 IST

Dabur Gets Green Light for Sesa Care Amalgamation — This image is AI-generated and does not depict any real-life event or location. It is a fictional representation created for illustrative purposes only.

Country:
India

Home-grown FMCG giant Dabur received some positive news as the Bombay Stock Exchange (BSE) issued a 'no adverse observations' letter regarding its Scheme of Amalgamation with Sesa Care. This development marks a significant milestone in Dabur's journey towards consolidating its stake in the Ayurvedic hair care market.

The observation letter from the BSE is a critical step in any corporate restructuring, indicating that the proposed merger does not face any immediate obstacles from the exchange's perspective. However, Dabur's merger scheme still awaits various statutory and regulatory approvals, as well as the consent of shareholders and creditors involved.

Dabur had broadened its influence in the Ayurvedic sector by acquiring the majority stake in Sesa Care back in 2024, with the full merger plan receiving board approval by May 2025. Sesa Care's strong brand equity in the Ayurvedic hair care industry complements Dabur's expansion strategy.

(With inputs from agencies.)